Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 69 results for "julie masow"

Generic Drug Zarxio Approved by FDA
The Guardian Express

FDA approval of first generic multiple sclerosis drug will boo...

Federal regulators Thursday approved the first generic multiple sclerosis therapy, in a development that could drop the price of the drug for consumers and boost the business of Momenta Pharmaceuticals Inc., which developed the injectable treatment. Boston Globe, 4 days ago
Generic Drug Zarxio Approved by FDA The Guardian Express, 1 month ago

AdverseEvents: Analysis of side-effect reports turns up troubling safety signals for Novartis, Eisai drugs

Drugs that treat brain-related diseases are often tied to troubling side effects, with companies listing everything from gambling compulsions and hypersexuality to mood changes and gastrointestinal bleeding on FDA-approved labels. Now an analysis of ...
 FiercePharma1 week ago

Novartis presents Cosentyx(tm) two-year efficacy and safety data showing

sustainable effect in psoriasis patients 03/21 06:04 CDT sustainable effect in psoriasis patients- New data at AAD shows 7 out of 10 psoriasis patients who were PASI 75 responders at 52 weeks achieved clear to almost clear skin (PASI 90) after ...
 Finwin1 month ago Novartis presents Cosentyx two-year efficacy and safety data showing sustainable effect in psoriasis patients  Tamar Securities1 month ago Novartis presents Cosentyx??? two-year efficacy and safety data showing sustainable effect in psoriasis patients  Review Seeker1 month ago Novartis presents Cosentyx„¢ two-year efficacy and safety data showing sustainable effect in psoriasis patients  TickerTech.com1 month ago

New Novartis data show more Cosentyx-treated psoriasis patients achieved clear or almost clear skin (PASI 90) compared to Stelara®

/PRNewswire/ --Novartis today announced results from the CLEAR study demonstrating Cosentyx (secukinumab) improved skin clearance at Week 16 in significantly more moderate-to-severe plaque psoriasis patients compared to Stelara ® * (ustekinumab), a ...
 Vision Monday1 month ago
Miami Herald

Patients could save billions with first lower-cost copy of biotech drug

WASHINGTON — Federal health officials on Friday approved the first lower-cost copy of a biotech drug in the U.S., a long-awaited milestone that could save billions for insurers, doctors and patients. Biotech drugs are powerful, injected medicines ...
 Denver Post1 month ago FDA approval of Novartis drug opens door to lower-cost biotech medicines in US  Canadian Business Magazine1 month ago FDA Approves Lower-Cost Biotech Drug  Epoch Times1 month ago First biosimilar drug approved by FDA, cheaper biotech medication on way  SiliconValley.com1 month ago

Cheaper Biotech Drugs Come to U.S. as Novartis Gets FDA Nod

(Updates with price discussion in sixth paragraph) The Food and Drug Administration cleared the imitation of the bioengineered drug, which Novartis will call Zarxio, according to a statement from the agency. Novartis agreed to delay selling the ...
 Washington Post1 month ago Novartis receives FDA approval of Farydak®, the first HDAC inhibitor for patients with multiple myeloma  TickerTech.com1 month ago

Novartis' : heart failure medicine LCZ696 granted FDA priority review»

Decision could speed access to LCZ696 for HFrEF patients in the US, reducing total review time from 12 to 8 months Filing is based on results from the landmark PARADIGM-HF study[1] Nearly six million people live with heart failure in the US, ...
 4 Traders1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less